Anne M. Rochtus

Prof. Dr. Anne M. Rochtus

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2020 in Epilepsia
Verified
Journal Article
Closed access
PDF file
ARAnne M. Rochtus
Anne M. Rochtus
HOHeather E. Olson
Heather E. Olson
LSLacey Smith
Lacey Smith
LKLouisa G. Keith
Louisa G. Keith
CAChristelle El Achkar
Christelle El Achkar
APAnnapurna Poduri
Annapurna Poduri

9 November 2021 in Epilepsia
Verified
Journal Article
Closed access
PDF file
ARAnne M. Rochtus
Anne M. Rochtus
DHDorien Herijgers
Dorien Herijgers
KJKatrien Jansen
Katrien Jansen
BDBrigitte Decallonne
Brigitte Decallonne

25 May 2020 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
ARAnne M. Rochtus
Anne M. Rochtus
RGRichard D. Goldstein
Richard D. Goldstein
IHIngrid A. Holm
Ingrid A. Holm
CBCatherine A. Brownstein
Catherine A. Brownstein
EPEduardo Pérez‐Palma
Eduardo Pérez‐Palma
APAnnapurna H. Poduri
Annapurna H. Poduri
Background: Sudden Unexpected Death in Pediatrics (SUDP) is a tragic event, likely caused by the complex interaction of multiple factors. The presence of hippocampal abnormalities in many children with SUDP suggests that epilepsy‐related mechanisms may contribute to death, similar to Sudden Unexplained Death in Epilepsy. Because of known associations between the genes SCN1A and SCN5A and sudden death, and shared mechanisms and patterns of expression in genes encoding many voltage‐gated sodium channels (VGSCs), we hypothesized that individuals dying from SUDP have pathogenic variants across the entire family of cardiac arrhythmia‐ and epilepsy‐associated VGSC genes.Methods: To address this hypothesis, we evaluated whole‐exome sequencing data from infants and children with SUDP for variants in VGSC genes, reviewed the literature for all SUDP‐associated variants in VGSCs, applied a novel paralog analysis to all variants, and evaluated all variants according to American College of Medical Genetics and Genomics (ACMG) guidelines.Results: In our cohort of 73 cases of SUDP, we assessed 11 variants as pathogenic in SCN1A, SCN1B, and SCN10A, genes with long‐standing disease associations, and in SCN3A, SCN4A, and SCN9A, VGSC gene paralogs with more recent disease associations. From the literature, we identified 82 VGSC variants in SUDP cases. Pathogenic variants clustered at conserved amino acid sites intolerant to variation across the VGSC genes, which is unlikely to occur in the general population (p < .0001). For 54% of variants previously reported in literature, we identified conflicting evidence regarding pathogenicity when applying ACMG criteria and modern population data.Conclusion: We report variants in several VGSC genes in cases with SUDP, involving both arrhythmia‐ and epilepsy‐associated genes. Accurate variant assessment as well as future studies are essential for an improved understanding of the contribution of sodium channel‐related variants to SUDP.

6 August 2024 in Children
Verified
Journal Article
Open access
PDF file
FVFemke De Vleeschhauwer
Femke De Vleeschhauwer
KCKristina Casteels
Kristina Casteels
IHIlse Hoffman
Ilse Hoffman
MPMarijke Proesmans
Marijke Proesmans
ARAnne M. Rochtus
Anne M. Rochtus
Topical corticosteroids are a mainstay in the treatment of many pediatric disorders. While they have proven beneficial therapeutic effects and are generally considered safe, systemic adverse events may occur. This study presents four cases of children who experienced systemic adverse events after using inhaled and intranasal topical corticosteroids, as well as topical corticosteroids in other forms. A comprehensive literature review was performed to explore the existing evidence on this topic. The aim of this study is to raise awareness among healthcare providers about the possibility of systemic adverse events associated with the use of locally administered corticosteroids in pediatric patients. This information underscores the importance of careful monitoring, individualized treatment plans, and further research to better understand and mitigate the risks associated with corticosteroids, even those not given systemically.

24 April 2020 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
CLChiara De Luca
Chiara De Luca
YCYanick J. Crow
Yanick J. Crow
MRMathieu Rodero
Mathieu Rodero
GRGillian I. Rice
Gillian I. Rice
MAMelek Ahmed
Melek Ahmed
ARAnne M. Rochtus
Anne M. Rochtus

5 February 2020 in International Journal of Pediatric Endocrinology
Verified
Journal Article
Open access
PDF file
ARAnne M. Rochtus
Anne M. Rochtus
JVJoseph Vinckx
Joseph Vinckx
FZFrancis de Zegher
Francis de Zegher
Background: Intracranial lipomas are rare, congenital lesions, most often located at the midline. Most hypothalamic lipomas are asymptomatic, but some cases have been associated with precocious puberty, hypothermia, headache and/or obesity.Case presentation: A 7-year-old boy was referred for short stature and proved to be partially growth-hormone deficient. Magnetic resonance imaging (MRI) revealed a lipoma in the paramedian hypothalamus. Growth hormone treatment resulted in swift and uncomplicated catch-up growth.Conclusions: The present case appears to be the first to link hypothalamic lipoma to GH deficiency. The neuro-endocrine pathophysiology underpinning this link remains to be explored.